PMC:7253482 / 0-268
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2 | 19-30 | Species | denotes | coronavirus | Tax:11118 |
3 | 31-37 | Chemical | denotes | glycan | MESH:D011134 |
25 | 133-186 | Species | denotes | Middle East respiratory syndrome (MERS) coronaviruses | Tax:1335626 |
26 | 188-192 | Species | denotes | CoVs | Tax:11118 |
39 | 88-121 | Disease | denotes | Severe acute respiratory syndrome | MESH:D045169 |
40 | 123-127 | Disease | denotes | SARS | MESH:D045169 |
41 | 198-206 | Disease | denotes | zoonotic | MESH:D015047 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 88-121 | Disease | denotes | Severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 123-127 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 207-216 | http://purl.obolibrary.org/obo/IDO_0000528 | denotes | pathogens |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T0 | 0-15 | NNS | denotes | Vulnerabilities |
T1 | 16-18 | IN | denotes | in |
T2 | 19-30 | NN | denotes | coronavirus |
T3 | 31-37 | NN | denotes | glycan |
T4 | 38-45 | NNS | denotes | shields |
T5 | 46-53 | IN | denotes | despite |
T6 | 54-63 | JJ | denotes | extensive |
T7 | 64-77 | NN | denotes | glycosylation |
T8 | 79-87 | NN | denotes | Abstract |
T9 | 88-94 | JJ | denotes | Severe |
T10 | 95-100 | JJ | denotes | acute |
T11 | 101-112 | JJ | denotes | respiratory |
T12 | 113-121 | NN | denotes | syndrome |
T13 | 122-123 | -LRB- | denotes | ( |
T14 | 123-127 | NN | denotes | SARS |
T15 | 127-128 | -RRB- | denotes | ) |
T16 | 129-132 | CC | denotes | and |
T17 | 133-139 | NNP | denotes | Middle |
T18 | 140-144 | NNP | denotes | East |
T19 | 145-156 | JJ | denotes | respiratory |
T20 | 157-165 | NN | denotes | syndrome |
T21 | 166-167 | -LRB- | denotes | ( |
T22 | 167-171 | NNS | denotes | MERS |
T23 | 171-172 | -RRB- | denotes | ) |
T24 | 173-186 | NNS | denotes | coronaviruses |
T25 | 187-188 | -LRB- | denotes | ( |
T26 | 188-192 | NNS | denotes | CoVs |
T27 | 192-193 | -RRB- | denotes | ) |
T28 | 194-197 | VBP | denotes | are |
T29 | 198-206 | JJ | denotes | zoonotic |
T30 | 207-216 | NNS | denotes | pathogens |
T31 | 217-221 | IN | denotes | with |
T32 | 222-226 | JJ | denotes | high |
T33 | 227-235 | NN | denotes | fatality |
T34 | 236-241 | NNS | denotes | rates |
T35 | 242-245 | CC | denotes | and |
T36 | 246-254 | JJ | denotes | pandemic |
T37 | 255-264 | NN | denotes | potential |
R6 | T7 | T6 | arg1Of | glycosylation,extensive |
R7 | T12 | T9 | arg1Of | syndrome,Severe |
R8 | T12 | T10 | arg1Of | syndrome,acute |
R9 | T12 | T11 | arg1Of | syndrome,respiratory |
R0 | T0 | T1 | arg1Of | Vulnerabilities,in |
R1 | T4 | T1 | arg2Of | shields,in |
R2 | T4 | T2 | arg1Of | shields,coronavirus |
R3 | T4 | T3 | arg1Of | shields,glycan |
R4 | T0 | T5 | arg1Of | Vulnerabilities,despite |
R5 | T7 | T5 | arg2Of | glycosylation,despite |
R10 | T12 | T13 | arg1Of | syndrome,( |
R11 | T14 | T13 | arg2Of | SARS,( |
R12 | T15 | T13 | arg3Of | ),( |
R13 | T12 | T16 | arg1Of | syndrome,and |
R14 | T20 | T16 | arg2Of | syndrome,and |
R15 | T18 | T17 | arg1Of | East,Middle |
R16 | T20 | T18 | arg1Of | syndrome,East |
R17 | T20 | T19 | arg1Of | syndrome,respiratory |
R18 | T20 | T21 | arg1Of | syndrome,( |
R19 | T22 | T21 | arg2Of | MERS,( |
R20 | T23 | T21 | arg3Of | ),( |
R21 | T28 | T24 | arg1Of | are,coronaviruses |
R22 | T24 | T25 | arg1Of | coronaviruses,( |
R23 | T26 | T25 | arg2Of | CoVs,( |
R24 | T27 | T25 | arg3Of | ),( |
R25 | T16 | T28 | arg1Of | and,are |
R26 | T30 | T28 | arg2Of | pathogens,are |
R27 | T30 | T29 | arg1Of | pathogens,zoonotic |
R28 | T30 | T31 | arg1Of | pathogens,with |
R29 | T35 | T31 | arg2Of | and,with |
R30 | T34 | T32 | arg1Of | rates,high |
R31 | T34 | T33 | arg1Of | rates,fatality |
R32 | T34 | T35 | arg1Of | rates,and |
R33 | T37 | T35 | arg2Of | potential,and |
R34 | T37 | T36 | arg1Of | potential,pandemic |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T1 | 88-121 | Species | denotes | Severe acute respiratory syndrome | NCBItxid:694009 |
T2 | 123-127 | Species | denotes | SARS | NCBItxid:694009 |
T3 | 167-171 | Species | denotes | MERS | NCBItxid:1335626 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-77 | Sentence | denotes | Vulnerabilities in coronavirus glycan shields despite extensive glycosylation |
T2 | 79-87 | Sentence | denotes | Abstract |
T3 | 88-265 | Sentence | denotes | Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 88-121 | Disease | denotes | Severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 123-127 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
2 | 19-30 | Species | denotes | coronavirus | Tax:11118 |
3 | 31-37 | Chemical | denotes | glycan | MESH:D011134 |
39 | 88-121 | Disease | denotes | Severe acute respiratory syndrome | MESH:D045169 |
40 | 123-127 | Disease | denotes | SARS | MESH:D045169 |
25 | 133-186 | Species | denotes | Middle East respiratory syndrome (MERS) coronaviruses | Tax:1335626 |
68 | 173-186 | Species | denotes | coronaviruses | Tax:11118 |
69 | 188-192 | Species | denotes | CoVs | Tax:11118 |
26 | 188-192 | Species | denotes | CoVs | Tax:11118 |
41 | 198-206 | Disease | denotes | zoonotic | MESH:D015047 |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 64-77 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 64-77 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 64-77 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-77 | Sentence | denotes | Vulnerabilities in coronavirus glycan shields despite extensive glycosylation |
T2 | 79-87 | Sentence | denotes | Abstract |
T3 | 88-265 | Sentence | denotes | Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. |